Home > Annual Financials > FISCHER MEDICAL VENTURES

FISCHER MEDICAL VENTURES Financial Statement Analysis
[BOM: 524743|NSE : FISCHER]

The Revenues of FISCHER MEDICAL VENTURES have increased by 427.62% YoY .
The Earnings Per Share (EPS) of FISCHER MEDICAL VENTURES has decreased by -11.54 % YoY.
COMMUNITY POLL
for FISCHER MEDICAL VENTURES
Please provide your vote to see the results

FISCHER MEDICAL VENTURES Last 5 Annual Financial Results
[BOM: 524743|NSE : FISCHER]

ConsolidatedMar2025
Mar2024
Mar2023
Revenues ₹111 Cr₹21 Cr₹0.18 Cr
Expenses ₹107 Cr₹19 Cr₹0.16 Cr
Operating Profit (Excl OI) ₹3.34 Cr₹1.86 Cr₹0.02 Cr
Other Income ₹1.49 Cr₹0.50 Cr₹0.00 Cr
Interest ₹0.49 Cr₹0.07 Cr₹0.02 Cr
Depreciation ₹1.63 Cr₹0.18 Cr₹0.00 Cr
Profit Before Tax ₹2.22 Cr₹2.11 Cr₹0.00 Cr
Profit After Tax ₹1.21 Cr₹1.84 Cr₹-0.04 Cr
Consolidated Net Profit ₹1.48 Cr₹1.38 Cr₹-0.04 Cr
Earnings Per Share (Rs)₹0.23₹0.26₹-2.12
PAT Margin (%)1.098.76-20.33
ROE(%)0.624.600.00
ROCE(%)1.135.354.97
Total Debt/Equity(x)0.200.00-2.15

Key Financials

Market Cap : ₹ 2,734.5 Cr
Revenue (TTM) : ₹ 308.6 Cr
Net Profit(TTM) : ₹ 31.1 Cr
EPS (TTM) : ₹ 0.5
P/E (TTM) : 87.9

Industry Peers & Returns1W1M1Y
FISCHER MEDICAL VENTURES 8.9% 2.1% -56.2%
ADANI ENTERPRISES -3.1% -0.3% 28%
PREMIER ENERGIES -3.1% -1.7% 2.1%
ADITYA INFOTECH 2.4% 40.7% NA
AEGIS LOGISTICS 9.7% 64.5% 44.9%
REDINGTON -1.5% 23.7% -2.3%
RRP SEMICONDUCTOR -3.9% -19% 6338.6%
HONASA CONSUMER 7.5% 6.3% 38.4%
LLOYDS ENTERPRISES -3.1% 0.7% 14.2%


FISCHER MEDICAL VENTURES Revenues
[BOM: 524743|NSE : FISCHER]

Y-o-Y

427.62 %

5 Yr CAGR

2,379.91 %

Years Revenues % Change
Mar2025 ₹111 Cr
427.62
Mar2024 ₹21 Cr
11,556.11
Mar2023 ₹0.18 Cr -


FISCHER MEDICAL VENTURES Operating Profit
[BOM: 524743|NSE : FISCHER]

Y-o-Y

79.78 %

5 Yr CAGR

1,393.10 %

Years Operating Profit % Change
Mar2025 ₹3.34 Cr
79.78
Mar2024 ₹1.86 Cr
12,300.00
Mar2023 ₹0.02 Cr -

Operating Margins
Y-o-Y

-65.95 %

5 Yr CAGR

-39.79 %

Years Operating Margin% % Change
Mar2025 3.02%
-65.95
Mar2024 8.87%
6.48
Mar2023 8.33% -

FISCHER MEDICAL VENTURES Profit After Tax
[BOM: 524743|NSE : FISCHER]

Y-o-Y

7.55 %

5 Yr CAGR

Positive

Years Profit After Tax % Change
Mar2025 ₹1.48 Cr
7.55
Mar2024 ₹1.38 Cr
Positive
Mar2023 ₹-0.04 Cr -

PAT Margins
Y-o-Y

-87.56 %

5 Yr CAGR

Positive

Years PAT Margin(%) % Change
Mar2025 1.09 %
-87.56
Mar2024 8.76 %
Positive
Mar2023 -20.33 % -

FISCHER MEDICAL VENTURES Earnings Per Share (EPS)
[BOM: 524743|NSE : FISCHER]

Y-o-Y

-11.54 %

5 Yr CAGR

Positive

Years EPS % Change
Mar2025 ₹0.23
-11.54
Mar2024 ₹0.26
Positive
Mar2023 ₹-2.12 -

FISCHER MEDICAL VENTURES Return on Capital Employed (ROCE)
[BOM: 524743|NSE : FISCHER]

Y-o-Y

-78.88 %

5 Yr CAGR

-52.32 %

Years ROCE % Change
Mar2025 1.13%
-78.88
Mar2024 5.35%
7.65
Mar2023 4.97% -

FISCHER MEDICAL VENTURES Share Price vs Sensex

Current Share Price : ₹41.8
Current MarketCap: ₹ 2,734.5 Cr
Updated EOD on :Jun 30,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
FISCHER MEDICAL VENTURES

8.9%

2.1%

-56.2%

SENSEX

-0.8%

0.8%

-7.2%

FISCHER MEDICAL VENTURES related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 2.2% 3.9% 14.5%
BSE 1000 -1% 0.5% NA
No NSE index found

You may also like the below Video Courses


FAQ about FISCHER MEDICAL VENTURES Financials


How the annual revenues of FISCHER MEDICAL VENTURES have changed ?

The Revenues of FISCHER MEDICAL VENTURES have increased by 427.62% YoY .

How the Earnings per Share (EPS) of FISCHER MEDICAL VENTURES have changed?

The Earnings Per Share (EPS) of FISCHER MEDICAL VENTURES has decreased by -11.54 % YoY .